Know Your Patient's Liver Health
LiverFASt™ is a blood based diagnostic test utilizing a patented algorithm to determine presence and the progression of liver disease. The test is non-invasive, simple, and less expensive than liver biopsy or liver imaging.
LiverFASt™ is capable of detecting and grading levels of Steatosis (fat accumulation), Activity (inflammation) & Scarring (Fibrosis) of the liver.
LiverFASt™ is capable of detecting and grading levels of Steatosis (fat accumulation), Activity (inflammation) & Scarring (Fibrosis) of the liver.
How It Works
The LiverFASt™ algorithm was developed via machine-learning. The development process leveraged the data of thousands of patients to combine the parameters of age, gender, BMI and 9 unique blood biomarkers.
The primary output are ‘scores’ that indicate a patient’s level of liver injury and stage of liver disease.
The primary output are ‘scores’ that indicate a patient’s level of liver injury and stage of liver disease.
Non-invasive liver screen tests are utilized around the world and have proven to be an effective alternative testing method to biopsy and imaging, offering accuracy and minimizing the cost and associated risks
Detection
Early detection of Steatosis, NASH & Fibrosis
Proactive Care
Mitigation of late stage liver disease and associated complications
Motivation
Drive positive behavior and life style change among patients
Monitoring
Monitor impact of treatment and intervention on liver health over time
More to Offer
Broaden practice offering & create a more comprehensive screening program
Cost Reduction
Accurate and repeatable alternative to costly biopsy and imaging
